A Urinary Tract Infection Evolved Into Brain-Invading Bacteria in the Same Patient, Doctors Report

A UTI That Wouldn't Stay Put

A 63-year-old woman showed up at a hospital in pain, having suddenly lost vision in her right eye. That single symptom kicked off a diagnostic chain that ended somewhere doctors did not expect: her brain, according to a case report published this week in the New England Journal of Medicine and detailed by Ars Technica.

MRI scans found inflammation in her eye and lesions in her parietal lobe, the part of the brain that handles sensory processing. Blood and urine tests pointed to infection and kidney trouble. Suspecting a brain abscess, surgeons opened her skull and found pus.

One Bacterium, Three Samples, Two Different Personalities

Lab work on two urine samples and the brain tissue all identified the same culprit: Klebsiella pneumoniae, a bacterium doctors know well. It normally lives in the gut but causes plenty of trouble in hospitals, including pneumonia and urinary tract infections. A more dangerous variant of it can go "metastatic," spreading through the bloodstream to the liver, lungs, eyes, or brain.

The bacteria from the first urine sample looked like standard K. pneumoniae under the microscope. But the bacteria from the second urine sample and from the brain tissue looked different: gloopy, sticky, wrapped in a thick capsule, according to Ars Technica's account of the NEJM report.

That capsule mattered. Researchers testing the samples found the thick-coated bacteria could dodge macrophages, the immune cells whose job is to gobble up invaders. In mice, the sticky, capsule-heavy version was lethal. The normal-looking version was not. Both samples that carried the thick coating met the clinical definition of hypervirulent K. pneumoniae, the strain type associated with spreading to organs beyond the urinary tract.

A Trade-Off Built Into the Mutation

The upgrade to hypervirulence wasn't free for the bacteria. The thicker-coated version grew more slowly than its plain cousin and was worse at infecting bladder cells, according to the case report. Evolution, even inside a single human body, apparently still runs on trade-offs: better at evading immune defense and spreading to organs, worse at multiplying fast or colonizing the bladder efficiently.

Genome sequencing tied all three samples together as closely related, meaning this wasn't a case of the woman picking up a second, nastier infection somewhere along the way. It was the same bacterial population changing over time inside her, most notably losing a hallmark gene tied to its original form, per the NEJM findings described by Ars Technica.

Why This Case Stands Out

Most of what's understood about bacterial evolution and antibiotic resistance comes from comparing strains across different patients or tracking outbreaks between hospitals. This case documents evolution happening within one person, over roughly two years, ending with a plain UTI bug turning into something capable of invading the brain.

Compared to population-level surveillance, this is narrower and more direct evidence. It shows that a chronic or recurring infection isn't necessarily static. Given enough time and the right conditions, the bacteria causing it can change shape, change behavior, and change how dangerous they are, even without a new source of infection.

What's Still Unknown

The published case report does not specify exactly what triggered the shift toward the hypervirulent, capsule-heavy form, nor does it establish how common this kind of in-patient evolution actually is outside of documented case reports. Klebsiella pneumoniae is already flagged by health authorities as a pathogen of concern because of rising antibiotic resistance, but this case is about virulence evolving, not necessarily resistance.

What happened to the woman after treatment, including whether she recovered vision in her eye or what antibiotic regimen was used to clear the infection, was not detailed in the available reporting on the case. Researchers involved in the case, cited by Ars Technica, treated the finding as a rare, documented instance of a pathogen changing its own risk profile mid-infection, a reminder that a UTI left to run its course over years is not guaranteed to stay a UTI.